Compare Boston Scientific Corporation (BSX) vs Thomson Reuters Corp (TRI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Boston Scientific Corporation vs Thomson Reuters Corp — how do they compare? Boston Scientific Corporation trades at $51 (market cap $74.19B), while Thomson Reuters Corp trades at $104.52 (market cap $45.38B). The key difference: Boston Scientific Corporation is the larger of the two by market cap, and Thomson Reuters Corp pays a 2.5% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | TRI | |
|---|---|---|
Market Cap | $74.19B | $45.38B |
Sector | Health | Industrials |
52-Week High | $108.14 | $178.77 |
52-Week Low | $42.63 | $76.55 |
Enterprise Value | $86.27B | $48.00B |
Dividend Yield | — | 2.5% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →About Thomson Reuters Corp
Thomson Reuters is the result of the $17.6 billion megamerger of Canada's Thomson and the United Kingdom's Reuters Group in 2008 and the 2018 carve-out of its finance and risk business, Refinitiv, in which it holds a 45% stake. In 2019, the company agreed to exchange its 45% stake in Refinitiv for a 15% stake in LSE, which closed in early 2021. Since the divestiture, the company is more concentrated on selling its flagship legal data and software, Westlaw, and its tax accounting software, Onesource. Reuters sees roughly 80% of revenue and 70% of expenses attributed to the United States, while the remainder (largely through the global print and Reuters News segments) is distributed across Latin America, Europe, the Middle East, Africa, and Asia-Pacific.
Read more on TRI →
